Intraoral chilling versus oral sumatriptan for acute migraine

Heart Disease

Volumn 3, Issue 6, 2001, Pages 357-361

  Friedman, M H ^a   Peterson, S J ^a   Behar, C F ^a   Zaidi, Z ^a  

^a NONE   (United States)

Author keywords

Local inflammation; Maxillary chilling; Migraine; Sumatriptan

Indexed keywords

ICE; PLACEBO; SUMATRIPTAN; WATER;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INDUCED HYPOTHERMIA; INFLAMMATION; MALE; MIGRAINE; MOUTH; NAUSEA; PARESTHESIA; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; VERTIGO;

EID: 0035658409     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00132580-200111000-00003     Document Type: Article

References (36)

1. Migraine: A platelet disorder
2. Serotonin metabolism in migraine
3. Calcium-channel blockers in the treatment of migraine
4. The neurobiology of vascular head pain
5. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
6. Interpreting vessel diameter changes in vascular headache
7. Migraine headache
8. Ipsilateral intraoral tenderness and elevated temperature during unilateral headache
9. Atypical facial pain: The consistency of ipsilateral maxillary area tenderness and elevated temperature
10. An alternative approach to acute headache treatment: An emergency department pilot study
11. Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100mg) in the acute treatment of migraine: Defining the optimum doses of oral sumatriptan
12. Efficacy and tolerability of rizatriptan 10 mg in migraine: Experience with 70,527 patient episodes
13. Coronary side-effect potential of current and prospective anti-migraine drugs
14. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain
15. Head and neck pain review: Traditional and new perspectives
16. ID, receptor agonists rizatriptan (MK-462) and sumatriptan in human isolated coronary artery: Outcome of two independent studies using different experimental protocols
17. Botulinum toxin type A as a migraine preventative treatment
18. Treatment of tension-type headache with botulinum toxin type A: A double-blind placebo-controlled study
19. Treatment of chronic cervical-associated headache with botulinum toxin type A: A pilot study
20. Treatment of tension-type headache by local injection of botulinum toxin type A
21. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain
22. The feasibility of palpating the lateral pterygoid muscle
23. Neglected conditions producing preauricular and referred pain
24. Treatment of chronic tension headache
25. Intractable chronic daily headache: A persistent neurobiobehavioral disorder
26. Is chronic tension-type headache a vascular headache? The relation between chronic tension-type headache and cranial hemodynamics
27. Review of pain-measurement tools
28. Methodology of clinical trials of sumatriptan in migraine and cluster headache
29. Sumatriptan: An oral dosedefining study
30. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain
31. Intranasal sumatriptan for the acute treatment of migraine